Insulet Corp.
PODD
Rank in Stocks
#2100
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Share Price
$140.99
Last synced: 2026-10-16
Market Cap
$9.78B
Change (1 day)
1.60%
Change (1 year)
-55.75%
Country
US
Trade Insulet Corp. (PODD)
Category
Healthcare
Earnings for Insulet Corp. (PODD)
Earnings in Jun 2026 TTM: $494.70M
According to Insulet Corp. latest financial reports the company's current earnings are $494.70M. In 2023 the company made an earning of $214.60M, an increase over its 2022 earnings that were of $9.80M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Insulet Corp. from 2002 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $494.70M | 64.79% |
| 2024 | $300.20M | 39.89% |
| 2023 | $214.60M | 2,089.80% |
| 2022 | $9.80M | -52.20% |
| 2021 | $20.50M | 111.34% |
| 2020 | $9.70M | -33.10% |
| 2019 | $14.50M | 178.85% |
| 2018 | $5.20M | -119.55% |
| 2017 | $-26.60M | -0.81% |
| 2016 | $-26.82M | -56.32% |
| 2015 | $-61.39M | 28.22% |
| 2014 | $-47.88M | 6.70% |
| 2013 | $-44.87M | -13.13% |
| 2012 | $-51.66M | -9.45% |
| 2011 | $-57.04M | -6.73% |
| 2010 | $-61.16M | -15.46% |
| 2009 | $-72.34M | 0.00% |
| 2008 | 0.00 | 0.00% |
| 2007 | 0.00 | 0.00% |
| 2006 | 0.00 | 0.00% |
| 2005 | 0.00 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $7.51B | 1,418.29% |
US
|
|
| $5.56B | 1,024.52% |
IE
|
|
| $5.15B | 940.63% |
US
|
|
| $3.86B | 680.47% |
US
|
|
| - | - |
DE
|
